Reticulohistiocytosis

Reticulohistiocytosis
Synonyms	Multicentric reticulohistiocytosis, Lipoid dermatoarthritis
Pronounce	N/A
Specialty	N/A
Symptoms	Skin nodules, arthritis, joint pain
Complications	Joint destruction, disfigurement
Onset	Typically in adulthood
Duration	Chronic
Types	N/A
Causes	Unknown, possibly autoimmune
Risks	Middle-aged adults, females
Diagnosis	Clinical examination, biopsy
Differential diagnosis	Rheumatoid arthritis, gout, sarcoidosis
Prevention	N/A
Treatment	Immunosuppressive therapy, steroids, chemotherapy
Medication	N/A
Prognosis	Variable, can lead to joint damage
Frequency	Rare
Deaths	N/A

Reticulohistiocytosis is a rare disease that involves the overproduction of certain types of white blood cells known as histiocytes and dendritic cells. These cells then accumulate in the skin, mucous membranes, and internal organs, leading to a variety of symptoms.

Symptoms

The symptoms of reticulohistiocytosis can vary widely, depending on which parts of the body are affected. Common symptoms include:

• Skin lesions
• Joint pain and swelling (arthritis)
• Fever
• Fatigue
• Weight loss

In severe cases, the disease can also affect the heart, lungs, kidneys, and other internal organs.

Causes

The exact cause of reticulohistiocytosis is unknown. However, it is thought to be related to an abnormal response of the immune system. Some researchers believe that it may be triggered by an infection or other environmental factor.

Diagnosis

Reticulohistiocytosis is diagnosed based on the patient's symptoms, medical history, and a physical examination. Additional tests may include:

• Blood tests
• Biopsy of affected tissue
• Imaging tests such as X-rays or CT scans

Treatment

There is no cure for reticulohistiocytosis, but treatment can help manage symptoms. Treatment options may include:

• Corticosteroids to reduce inflammation
• Chemotherapy to slow the overproduction of white blood cells
• Surgery to remove large or bothersome skin lesions

Prognosis

The prognosis for people with reticulohistiocytosis varies. Some people have mild symptoms and a good quality of life with treatment. Others may have severe symptoms that are difficult to manage.

See also

• Histiocytosis
• Dendritic cells
• Immune system